RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

The OSA drug is awaiting phase 3 trials in Australia. As mentioned from my DD it appears most of the ducks are in a row and ready to launch. That company with the OSA drug was given 20+ million valuation, none of which reflected in current RSPI market cap. Now I guess what could be holding that up? They need some patent finality or FDA meeting or want additional funding before beginning, although seems like they have chunks already spoken for to begin??

It would seem beneficial to prospective shareholders and the company itself if they could update rough timelines/milestones with the two promising drugs (OSA and pain/epilepsy) and any others they have in the works. Although, maybe this will be one of those that just flounders in the .001-.003 range and then shoots past .05 in a matter of a few days....